Thalidomide and Lenalidomide: Dermatologic Uses

Overview / Definition Thalidomide and lenalidomide are both part of a class of drugs known as immunomodulatory drugs (IMiDs). Originally developed in the 1950s as a sedative, thalidomide was later found to cause severe teratogenic effects. However, it has since been repurposed for various medical conditions, especially in dermatology. Lenalidomide, a derivative of thalidomide, was developed to enhance efficacy while reducing toxicity. Epidemiology The use of thalidomide and lenalidomide in dermatology is primarily seen in specific populations: Thalidomide is indicated in patients suffering from erythema nodosum leprosum, a complication of leprosy, particularly in endemic regions. Lenalidomide is commonly used in patients with multiple myeloma and certain cutaneous lymphomas, with a growing body of evidence supporting its use in autoimmune skin disorders. Pathophysiology / Mechanism Both thalidomide and lenalidomide exert their effects primarily through immunomodulation: They inhibit the production of pro-inflammatory cytokines such as TNF-alpha and IL-6. These drugs enhance the activity of natural killer (NK) cells and promote apoptosis of malignant cells. Thalidomide also has anti-angiogenic properties, which can be beneficial in conditions characterized by excessive neovascularization. Clinical Presentation Dermatologic conditions treated with thalidomide and lenalidomide include: Erythema nodosum leprosum: Presents with painful, erythematous nodules, often associated with systemic symptoms. Cutaneous T-cell lymphoma (CTCL): May manifest as plaques, patches, or tumors on the skin. Other inflammatory skin disorders: Such as lupus erythematosus and behçet's disease. Diagnosis / Workup Diagnosis of conditions treated with thalidomide and lenalidomide typically involves: Clinical evaluation: Assessing the characteristic appearance of lesions and the presence of systemic symptoms. Histopathology: Skin biopsy may be necessary for definitive diagnosis, especially in susp